Asthma is a
chronic condition with high morbidity and healthcare costs, and cockroach
allergens are an established cause of urban pediatric
asthma. A better understanding of cell types involved in promoting
lung inflammation could provide new targets for the treatment of chronic
pulmonary disease. Because of its role in regulating myeloid cell-dependent inflammatory processes, we examined A(2B) R expression by myeloid cells in a cockroach
allergen model of murine
asthma-like
pulmonary inflammation. Both systemic and myeloid tissue-specific A(2B) R deletion significantly decreased pulmonary inflammatory cell recruitment, airway
mucin production, and proinflammatory
cytokine secretion after final
allergen challenge in sensitized mice. A(2B) R deficiency resulted in a dramatic reduction on Th2-type airways responses with decreased
pulmonary eosinophilia without augmenting neutrophilia, and decreased lung
IL-4,
IL-5, and
IL-13 production.
Chemokine analysis demonstrated that
eotaxin 1 and 2 secretion in response to repeated
allergen challenge is myeloid cell A(2B) R dependent. In contrast, there were no differences in the levels of the
CXC chemokines keratinocyte-derived
chemokine and MIP-2 in the myeloid cell A(2B) R-deficient mice, strengthening A(2B) R involvement in the development of Th2-type airways
inflammation. Proinflammatory TNF-α, IFN-γ, and
IL-17 secretion were also reduced in systemic and myeloid tissue-specific A(2B) R deletion mouse lines. Our results demonstrate Th2-type predominance for A(2B) R expression by myeloid cells as a mechanism of development of
asthma-like
pulmonary inflammation.